Healthtech Startups

Orvida Pharma develops pharmaceuticals for rare genetic skin diseases and orphan indications, with expertise spanning drug development from early discovery through FDA and EMA regulatory approval.

1 investor

Orvue is developing a single-use, robotic camera for laparoscopy that is controlled directly by the surgeon, replacing manual scope handling with robotic positioning for greater stability. The platform is designed for surgical use and intended to capture procedural data.

1 investor

OS Therapies (OST) is a clinical-stage cancer immunotherapy company developing treatments that activate the immune system to target HER2-expressing cancers, initially focusing on osteosarcoma in children and adults. It plans to expand its lead candidate into breast, colorectal, esophageal, lung, ovarian, and pancreatic cancers and other solid tumors.

1 investor

Osang Healthcare is an in-vitro diagnostic company that develops and manufactures biochemistry, immunology, and molecular diagnostic devices for global OEM and ODM partners. The company distributes diagnostic equipment to customers across more than 100 countries and plans to expand into digital health platforms and health supplements.

1 investor

OSAZ is a science-backed beauty brand formulating tinted mineral sunscreens and lip protection products designed to match diverse skin tones without grey cast or flashback. The company uses AI and skin data to develop inclusive SPF products for consumers across different climates and skin tones.

1 investor

Oscillum develops biosensors and active packaging additives for food, pharmaceutical, and cosmetic products. Its technologies enable real-time product monitoring and extend shelf life by preserving freshness and quality.

1 investor

OSF HealthCare is an integrated health system operating 16 hospitals, urgent care clinics, primary and specialty care facilities, and digital health services across Illinois and Michigan. The organization serves patients through inpatient care, outpatient clinics, home health services, and virtual care platforms.

1 investor

Osheru is a medical device company that developed the Ziplyft, a sutureless device and technique for eyelid surgery aimed at surgeons and patients. Its approach targets faster recovery and improved outcomes in oculoplastic and ophthalmic procedures.

1 investor

Osivax develops vaccines targeting conserved internal viral structures to provide broader and longer-lasting protection against influenza, leveraging its proprietary oligoDOM technology platform. The company originated from research co-developed with the University of Oxford and is supported by public health foundations and pharmaceutical partners.

1 investor

Oska Health provides continuous care management for people with chronic kidney disease, aiming to reduce complications, hospitalizations, and healthcare costs through integrated digital and clinical support.

1 investor

A medical device CRO (Contract Research Organization) and innovation platform that provides incubation, development, and commercialization services for medical devices and healthcare technologies in China and internationally.

1 investor

Ossianix develops TXP1, a brain-selective shuttle based on a deimmunised VNAR antibody scaffold that targets TfR1 to carry therapeutic payloads across the blood-brain barrier. The company focuses on improving delivery of central nervous system therapeutics to the brain.

1 investor

Domestic provider of speech and language therapy services for children with developmental and learning disorders, offering assessment, intervention, and early screening through a combination of localized international methodologies and expert supervision.

1 investor

Osteal Therapeutics is a clinical-stage pharmaceutical company developing novel treatments for orthopedic infections, particularly periprosthetic joint infections. Its lead product, NEXCHANGE KIT, is a drug-device combination designed for localized antibiotic delivery to infected joint prostheses.

1 investor

Osteocentric develops orthopedic implant systems for bone fixation, including fasteners, plates, and surgical instruments that use UnifiMI mechanical integration technology. The company serves orthopedic surgeons and hospitals treating fractures and skeletal injuries.

1 investor

Osteon Medical designs and manufactures titanium dental implant hardware, including single, bridge, and full-arch implant componentry, for dental labs and clinicians. The company operates milling and production facilities and develops digital implant solutions such as its Nexus system and intraoral scanning technology.

1 investor

OTOFARMA is an Italian manufacturer of custom hearing aids with ISO certification, sold exclusively through partnered pharmacies. The company also offers telemedicine audiology services, positioning itself as Italy's only certified hearing aid constructor with integrated remote consultations available in over 3,000 affiliated pharmacies.

1 investor

OtoImmune is developing precision immunology products under its mOI and mOI Health brands. The page provides no further detail about the specific products, technology, or target customers.

1 investor

Otolift manufactures and sells stairlifts for residential use, offering customizable solutions for straight and curved staircases.

1 investor

Otolith Labs develops a non-invasive, headworn wearable using patented Vestibular Resonance Therapy (nVRT) to treat vestibular conditions such as vestibular migraine and chronic vertigo. The device is a non-pharmacological medical product tested in clinical studies for patients suffering from balance and vertigo disorders.

1 investor

Otos is a platform that combines hearing and cognitive health assessment into a single system, with automated testing, triage, and continuous patient monitoring for integration into clinical workflows. It serves health systems, ENT and audiology practices, primary care, neurology, and longevity clinics, and is running clinical validation and pilot programs in Europe and the U.S.

1 investor

OTS Medical develops an FDA-cleared anchoring system for arthroscopic soft-tissue-to-bone reattachment in orthopaedic surgery, including the RAPHAEL 25 anchor that can be used with or without bone marrow. Its technology targets minimally invasive soft tissue repair for orthopaedic surgeons and patients in the United States and Europe.

1 investor

ounda GmbH is a Germany-wide group that brings together independent traditional opticians and hearing-aid acousticians under one umbrella, uniting over 100 independently branded specialist stores while preserving their local identities. Founded in 2019, it positions itself as a network (not a chain) for eyewear and hearing-care retailers across Germany.

1 investor

OurMind builds an AI platform for care professionals that takes routine clinical work such as documentation, intakes, referrals, scheduling, and follow-ups off care teams, letting clinicians create and train AI assistants across a hospital. It focuses on Dutch healthcare and is built to standards including MDR, the AI Act, NEN 7510, and ISO 27001.</parameter> <parameter name="hq_country">NL

1 investor